Rachel Rowlinson

AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer

Darren A.E. Cross, Susan Ashton, Serban Ghiorghiu et al. · Cancer Discovery · 2014 · 2.2K citations · Full text

Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology

Robert Tonge, Joanne Shaw, Brian Middleton et al. · PROTEOMICS · 2001 · 881 citations

Immunocytochemical Technique, Molecular Biology, Valid Thresholds +18

Evaluation of saturation labelling two‐dimensional difference gel electrophoresis fluorescent dyes

Joanne Shaw, Rachel Rowlinson, Janice Nickson et al. · PROTEOMICS · 2003 · 264 citations

Minimal Labelling, Biological Mass Spectrometry, Molecular Biology +21

Rapid isolation and enrichment of extracellular vesicle preparations using anion exchange chromatography

Nikki Heath, Lois R. Grant, Taianá Maia de Oliveira et al. · Scientific Reports · 2018 · 176 citations · Full text

AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and <i>ESR1</i> -Mutant Breast Tumors in Preclinical Models

Hazel M. Weir, Robert H. Bradbury, Mandy Lawson et al. · Cancer Research · 2016 · 174 citations